125 related articles for article (PubMed ID: 23261493)
1. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
Roten AT; Baker NL; Gray KM
Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
3. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
[TBL] [Abstract][Full Text] [Related]
4. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
5. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents.
McClure EA; Baker NL; Gray KM
Am J Drug Alcohol Abuse; 2014 Jul; 40(4):285-91. PubMed ID: 24720376
[TBL] [Abstract][Full Text] [Related]
7. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
Bentzley JP; Tomko RL; Gray KM
J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
[TBL] [Abstract][Full Text] [Related]
8. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Roten A; Baker NL; Gray KM
Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
[TBL] [Abstract][Full Text] [Related]
10. Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts.
Singleton EG; Trotman AJ; Zavahir M; Taylor RC; Heishman SJ
Exp Clin Psychopharmacol; 2002 Feb; 10(1):47-53. PubMed ID: 11871362
[TBL] [Abstract][Full Text] [Related]
11. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
Tomko RL; Gilmore AK; Gray KM
Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
[TBL] [Abstract][Full Text] [Related]
12. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
[TBL] [Abstract][Full Text] [Related]
13. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
14. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument.
Heishman SJ; Singleton EG; Liguori A
Addiction; 2001 Jul; 96(7):1023-34. PubMed ID: 11440613
[TBL] [Abstract][Full Text] [Related]
15. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
Chauchard E; Septfons A; Chabrol H
Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
[TBL] [Abstract][Full Text] [Related]
16. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.
Haughey HM; Marshall E; Schacht JP; Louis A; Hutchison KE
Addiction; 2008 Oct; 103(10):1678-86. PubMed ID: 18705688
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of a short form of the Marijuana Craving Questionnaire.
Heishman SJ; Evans RJ; Singleton EG; Levin KH; Copersino ML; Gorelick DA
Drug Alcohol Depend; 2009 Jun; 102(1-3):35-40. PubMed ID: 19217724
[TBL] [Abstract][Full Text] [Related]
19. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Cooper ZD; Foltin RW
Psychopharmacology (Berl); 2010 Aug; 211(2):233-44. PubMed ID: 20521030
[TBL] [Abstract][Full Text] [Related]
20. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.
Buckner JD; Zvolensky MJ; Crosby RD; Wonderlich SA; Ecker AH; Richter A
Drug Alcohol Depend; 2015 Feb; 147():20-5. PubMed ID: 25578250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
